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Summary Optical coherence tomography (OCT) is an optical analogue of intravascular ultra-
sound (IVUS), which provides high-resolution images of the coronary arteries up to 10m.
OCT allows us to demonstrate clearly culprit lesion morphologies in detail including types of
plaque, plaque disruption, thrombus, ﬁbrous cap thickness, and the frequency of thin-capped
ﬁbroatheroma (TCFA) in acute coronary syndrome (ACS), as described in previous histological
examinations. Furthermore, clinical silent disrupted plaques and non-ruptured TCFAs, which
are thought to be precursors of ACS and vulnerable plaques, have also been demonstrated by
OCT not only in culprit but also in non-culprit vessels in ACS. OCT also identiﬁed the mechanisms
of late thrombosis after bare-metal stent and drug-eluting stent implantation. Development of
the next-generation frequency-domain OCT system and prospective studies in a large popula-
tion may allow us to realize the pathophysiology of ACS in detail in vivo in humans, and these
may provide us new insights into the etiology and treatment of coronary artery disease in the
near future for predicting and preventing ACS.
© 2010 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
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Table 1 Criteria for deﬁning vulnerable plaques [16].
Major criteria
1. Active inﬂammation (monocyte/macrophage and
sometimes T-cell inﬁltration)
2. Thin cap with large lipid core
3. Endothelial denudation with superﬁcial platelet
aggregation
4. Fissured plaque
5. Stenosis > 90%
Minor criteria
1. Superﬁcial calciﬁed nodule
2. Glistening yellow
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Introduction
Optical coherence tomography (OCT) is a recently developed
intravascular imaging modality using near-infra-red light
(1300 nm) to create images [1—6]. Compared with various
other coronary imaging modalities, the greatest advantages
of OCT are its high resolution of up to 10m in an axial
resolution and to 20m in a lateral resolution, which is
approximately 10 times higher than that of intravascular
ultrasound (IVUS) and its accuracy of tissue characteriza-
tion [1—9]. OCT can clearly differentiate the three layers
of the coronary artery wall demonstrating the intima as the
signal-rich layer nearest the lumen, the media as the signal-
poor middle layer, and the adventitia as the signal-rich layer
surrounding the signal-poor layer of the media [6,10], and it
has also been reported that there is a signiﬁcant correlation
in the intima thickness between OCT and histology [11]. In
addition, OCT may allow us to identify tissue characteriza-
tion of coronary plaques much easier and clearer compared
with other imaging techniques [3,4,7—9,12,13] with very
good intra- and inter-observer reliabilities ( = 0.83—0.84)
and high sensitivity and speciﬁcity in each plaque demon-
strating 71—79% and 97—98% for ﬁbrous plaques, 95—96% and
97% for ﬁbro-calciﬁc plaques, and 90—94% and 90—92% for
lipid-rich plaques, respectively, in previous histological con-
trolled studies [12,13]. OCT demonstrates ﬁbrous plaques
as signal-rich, homogenous lesions, ﬁbro-calciﬁc plaques as
signal-poor, sharp-border lesions, and lipid-rich plaques as
signal-poor, diffuse border lesions [12] (Fig. 1), and these
deﬁnitions have formed the basis of plaque composition
interpretation in clinical OCT studies [7,8,14]. Furthermore,
in addition to the identiﬁcation of thrombus, OCT can dif-
ferentiate between red and white thrombi using a signal
attenuation curve with high sensitivity and speciﬁcity, and
these were difﬁcult for IVUS [15]. Thus, although there
would be some limitations in its shallow penetration depth
of the infra-red light beam, limited scan area, and complex
procedure of image acquisition by ﬂushing the blood away
using lactate Ringer’s solution or saline ﬂush, OCT provides
more detailed structural information of the coronary artery
wall and atherosclerotic plaque morphology compared to
conventional imaging methods [1—6], and these character-
istics of OCT are thought to be more suitable for evaluating
the culprit lesion morphology in acute coronary syndrome
(ACS) including acute myocardial infarction (AMI) and unsta-
ble angina pectoris (UAP) in vivo [2,6,14].
Pathohistology of culprit lesions in ACS
In vitro pathological studies [16—19] demonstrated that
most cases of ACS are thought to result from sudden luminal
narrowing caused by thrombosis based on plaque rupture,
erosion, and superﬁcial calciﬁed nodule. Within these three
different pathologies, plaque rupture has been reported to
be the most frequent (55—60%), plaque erosion to be the
second (30—35%) and superﬁcial calciﬁed nodule to be the
least (2—7%) [16—19]. Plaque rupture is deﬁned as a lesion
consisting of a large necrotic core with ruptured thin ﬁbrous
cap with overlying thrombus, and thin ﬁbrous cap athero-
mas (thin-cap ﬁbroatheromas: TCFAs) without rupture are
thought to be precursor lesions of ACS in pathology [18,19].
m
i
[
r
v3. Intraplaque hemorrhage
4. Endothelial dysfunction
5. Outward (positive) remodeling
laque erosion demonstrates intra-luminal thrombus with-
ut discontinuity of the thick ﬁbrous cap even in cases with
ecrotic core, although it is mostly devoid of a necrotic core
16,18,19]. Superﬁcial calciﬁed nodule, the least frequent
ause of intracoronary thrombus, reveals the discontinuity
f ﬁbrous cap without endothelial cells by bony calciﬁed
odule with overlying thrombus [16,18,19]. Based on these
hree different features of plaque morphology in the cul-
rit lesion in ACS, vulnerable plaques, which are deﬁned
s plaques prone to disruption and to be culprit plaques
ith thrombosis, are proposed by 5 major and 5 minor
riteria as listed in Table 1 [16]. Although most of these
roposal features are not identiﬁed in detail in vivo using
he previous imaging modalities, it is thought that OCT may
llow us to realize most of these characteristics in detail
n vivo in patients [1—6], and OCT examinations have been
pplied actively in the assessment of culprit lesion mor-
hology in ACS [7,8,14,20—22]. OCT might be the best tool
o assess vulnerable plaques in vivo human at the moment
1—6].
n vivo culprit lesion assessment in ACS by OCT
ulprit coronary lesion morphology in ACS in human was ﬁrst
eported using a 3.2 Fr proto-type OCT catheter in 2005 [14],
nd much more TCFA (72%, 50%, and 20% in AMI, UAP and sta-
le AP, respectively) has been demonstrated in addition to a
endency of frequent presence of plaque disruption, throm-
us, and lipid plaque with a signiﬁcantly thinner ﬁbrous
ap thickness in ACS compared with stable angina. The
requency of thrombus and plaque rupture in AMI in this
tudy was thought to be very low compared with patholog-
cal reports [16,18,19]; the size of the OCT catheter, the
iming of the study (4.6± 5.3 days after the onset), and
he use of thrombolysis and/or IIb/IIIa inhibitor adminis-
ration might affect the results. Lately, a similar frequency
f plaque rupture, erosion, and thrombus to the previous
istological studies have been reported in AMI using com-
ercially available OCT system with a 0.014 in. optic ﬁber
n a comparative study among OCT, IVUS, and angioscopy
20]. Furthermore, compared to IVUS and angioscopy, supe-
iorities of OCT in the detection of plaque rupture (73%
s. 40% vs. 43%, p = 0.021) (Fig. 2, left), erosion (23% vs.
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Figure 1 Optical coherence tomographic images of coronary atherosclerotic plaques. Fibrous plaque (left panel: signal-rich,
homogenous pattern), ﬁbro-calciﬁc plaque (middle panel: signal-poor, sharp-border pattern) and lipidic plaque (right panel: signal-
poor, diffuse border pattern) are demonstrated.
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Figure 2 Optical coherence tomographic images of disrupte
f ruptured ﬁbrous cap is 40m and crater formation is ident
yellow arrows) of thick ﬁbrous cap is observed with white thro
% vs. 3%, p = 0.003) (Fig. 2, right), and thrombus (100%
s. 33% vs. 100%, p < 0.001) have also been demonstrated
n this study. Frequency of TCFA (Fig. 3) in the initial and
ecent reports was 65% and 83%, respectively, and the thick-
ess of ﬁbrous cap in the former and latter studies was 47
nd 49± 21m, respectively [14,20]. There were no sig-
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igure 3 Optical coherence tomagraphic images of thin-capped ﬁque at culprit site in acute coronary syndrome. The thickness
within lipid plaque in a ruptured plaque (left) and ulceration
s (green arrows) in plaque erosion (right).
iﬁcant differences in these characteristics between men
nd women [21]. More interestingly, ﬁbrous cap thickness
nd the site of rupture have been reported to be differ-
nt in the type of ACS onset in a recent study [22], and it
s thinner (50m vs. 90m, respectively) in rest-onset ACS
ompared with exertion-triggered ACS, and the rupture at
broatheroma (TCFA). Various types of TCFA are demonstrated.
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wFigure 4 Optical coherence tomagraphic images of very late th
were identiﬁed under the tissue, and thin-capped ﬁbroatherom
protrusional mass in the lumen.
plaque shoulder is more frequent in the latter (57% vs. 93%).
Furthermore, not only TCFA but also thick cap (up to 150m)
ﬁbroatheroma (ThCFA) might have a chance to rupture, and
high-sensitive C-reactive protein level negatively correlates
well in proportion to the thickness of the ruptured ﬁbrous
cap. These ﬁndings suggest that various types of plaque dis-
ruption should occur in similar frequency even in vivo as
reported in vitro histology studies, and ﬁbrous cap rupture
could be expected at the site of plaque shoulder even in
ThCFA up to 150m during exertion. Exercise-induced high
shear stress at the site of the plaque shoulder might be spec-
ulated to be a cause of ﬁbrous cap disruption, although the
demonstration of inﬂammation by commercially available
OCT systems has not been established yet. However, the
possibility of macrophage accumulation by OCT has been
already described in the culprit lesion in ACS [23,24]. Lipid-
lowering therapy by statins may have a potential to increase
ﬁbrous cap thickness and stabilize plaque vulnerability by
reducing inﬂammation [25,26].
It has been reported recently that the frequency of
plaque rupture (43% vs. 13% vs. 71%, p < 0.001) and plaque
ulceration (32% vs. 7% vs. 8%, p = 0.003) are signiﬁcantly
different among the types of UAP in Braunwald class I, II,
and III, and the ﬁbrous cap thickness (140m vs. 150m
vs. 60m, p < 0.001), minimal lumen area (0.70mm2 vs.
1.80mm2 vs. 2.31mm2, p < 0.001), and the frequency of
thrombus (72% vs. 30% vs. 73%, p < 0.001) are also signiﬁ-
cantly different among the types of UAP, although lipid-rich
plaque is observed frequently in each group (85% vs. 80%
vs. 87%, p = 0.73) [27]. Although there has been no report
in the difference of rupture portions in the culprit plaques
by OCT as reported in a previous longitudinal IVUS analysis
between AMI and UAP [28], class III in UAP might be more
vulnerable than the other classes because plaque rupture in
TCFA overlying thrombus is more frequent even in enough
of the lumen area. In class I, organic luminal narrowing
and plaque ulceration with small amount of thrombus might
be a mechanism of ACS. Further comparative study among
ACSs in a large number would be required to demonstrate
the differences in the culprit lesion morphology in detail
in ACS.
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eosis following bare-metal stenting. Stent struts (green triangle)
e demonstrated within a neointima. Thrombus is observed as a
Stent thrombosis is also a cause of ACS, and TCFA within
tent has been recently reported as a cause of very late
tent thrombosis after bare-metal stent (BMS) implanta-
ion [29] (Fig. 4). Considering the high resolution, OCT
ay provide more detailed morphological information for
onitoring stent deployment and thin neointimal prolif-
ration after drug-eluting stent (DES) implantation than
onventional imaging methods [30—32]. OCT has an abil-
ty to detect stent edge dissection, tissue protrusion, and
tent malapposition more sensitively than IVUS [33]. Recent
CT studies demonstrated that the rate of sirolimus-eluting
tent struts with neointimal coverage was >90% at 12-month
ollow-up and most of them were covered by thin neointima
f <100m [30—32]. Presence of uncovered strut and/or
ncomplete apposition of strut, and positive remodeling of
he vessel by the drug have been proposed as potential
auses of late thrombosis after DES implantation [30—34].
hus, the mechanism of stent thrombosis resulting in ACS
ight be different between BMS and DES. Furthermore, to
etermine when antiplatelet therapy could be discontinued
fter DES implantation, OCT may provide important infor-
ation about chronic DES status.
etection of vulnerable plaque in vivo by OCT
ulnerable plaque, which is deﬁned as the plaque prone
o disruption and to be a culprit plaque with thrombus, is
hought to be TCFA in pathology as described previously
18,19]. However, not only TCFA itself but also blood coagu-
ability, vasomotor tone, and so on are thought to be related
o the onset of ACS, and the concept of the ‘‘vulnerable
atient’’ has been proposed to be more appropriate for
dentifying the vulnerable condition before the onset of ACS
16,17]. Multiple plaque disruptions demonstrated by OCT
ithin one vessel [35] or in the non-culprit vessel [36,37]
ay support this concept, and 5 major and 5 minor crite-
ia have been proposed for vulnerable plaques as described
n Table 1 [16]. Thus, OCT might be the best tool to iden-
ify vulnerable plaque by detecting 7—8 out of 10 criteria
xcept for glistening yellow color, endothelial dysfunction
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nd intraplaque hemorrhage [1—6], although glistening yel-
ow color plaque identiﬁed by angioscopy reveals TCFA by
CT and yellow color intensity of atherosclerotic plaque cor-
elates well to the thickness of ﬁbrous cap obtained by OCT
38]. In the feasibility study of OCT and virtual histology IVUS
or detecting TCFA [39], the high resolution of OCT allows
s to identify the thin ﬁbrous cap (<65m) [1—6], although
he positive ratio of virtual histology IVUS for detecting
CFA was 45.9% and that of OCT was 77.8% [39]. Kume et
l. demonstrated the abilities of OCT to identify throm-
us, and the presence of thrombus may also demonstrate
hat the plaque should be vulnerable [15]. Furthermore,
CT can differentiate red and white thrombus [15], and red
hrombi (red-blood-cell-rich) were demonstrated as a high-
ackscattering protrusion mass with signal-free shadowing
nside the vessel lumen, and white thrombi (platelet-rich)
ere revealed as low-backscattering projections [15]. Fur-
hermore, Tearney et al. descried the potential of OCT
o estimate macrophage accumulation within ﬁbrous caps
23,24]. There was a high degree of positive correlation
etween OCT and histological measurements of ﬁbrous cap
acrophage density (r < 0.84, p < 0.0001). A range of OCT
ignal standard deviation thresholds (6.15—6.35%) yielded
00% sensitivity and speciﬁcity for identifying caps con-
aining >10% CD68 staining in their study. The distribution
f TCFA in living patients assessed by OCT [40,41] is also
uite similar to the previous autopsy study [42]. Gold stan-
ard of histology is obtained from the autopsies of patients
ho died from ACS, and symptom-free plaque disruption
ould not be detected completely by autopsy except for
he examination of the non-culprit arteries. Three vessel
CT study may allow us to identify symptom-free disruption
n vivo and could be more accurate to identify vulnera-
le plaque compared with autopsy study [36,37,40,41], and
hen prospective OCT study would be required to know the
ulnerable plaque in vivo in the near future. Recently, it
as been reported that the density of vasa vasorum might
eﬂect plaque vulnerability [43], and microvascular struc-
ures demonstrating vasa vasorum are frequently identiﬁed
round the vulnerable plaque by OCT [44]. Thus, demonstra-
ion of microvascular structures by OCT may also provide
ulnerable plaque identiﬁcation.
imitations of OCT
he presently commercially available time-domain OCT (TD-
CT) system requires vessel occlusion by means of gentle
alloon inﬂation and vessel ﬂushing with lactate Ringers’
olution or saline infusion at the time of image acquisition
ecause the near-infra-red light signals are attenuated by
ed blood cells [1—6]. Therefore, observation of the proxi-
al portion of the vessels might be limited. To overcome
his limitation, a simpliﬁed technique for coronary blood
emoval which was achieved through continuous non-ionic
ontrast administration or dextran with lactate Ringers’
olution were recommended recently [45,46]. This non-
cclusive technique of OCT image acquisition is safe and
ffective, and promises to reduce the procedural time [46].
further limitation of OCT is the relatively shallow axial
enetration depth of 2mm as described previously. The OCT
ignal does not reach the back wall of thick atheroscleroticT. Akasaka et al.
esions. The current OCT is well suited for the assessment
f the plaque morphologies within 500m of the luminal
urface.
uture perspectives of OCT
ecently, a second-generation OCT technology, named
requency-domain OCT (FD-OCT), has been developed, and
his will solve the current TD-OCT limitations by imaging
t much higher frame rates with slightly deeper penetra-
ion depth and greater scan area [5,6,46]. In combination
ith a short, non-occlusive ﬂush and rapid spiral pullback,
he higher frame rates generated by FD-OCT enable imaging
f the three-dimensional microstructure of longer segments
f coronary arteries [47,48]. In addition, FD-OCT facilitates
he acquisition of spectroscopic and polarization data for
issue characterization [5,6], and identiﬁcation of vulnera-
le plaque and more precise and easier assessment of culprit
esion morphology in ACS could be expected in daily clinical
ractice.
onclusions
he high-resolution imaging modality of OCT provides
istology-grade deﬁnition of themorphology of culprit lesion
laques in ACS in vivo. TCFA disruption with thrombus is
ommonly observed at the culprit site as reported previ-
usly by histology. Non-ruptured TCFA and clinically silent
isrupted TCFA also can be demonstrated not only in cul-
rit but also in non-culprit vessels by OCT. Thus, OCT allows
greater understanding of the pathophysiology of ACS and
ay have a potential to propose guidance for the appropri-
te patient-speciﬁc therapeutic approach. Although more
linical research with greater number of subjects and
evelopment of the imaging technology are required, OCT
ill play an important role in the future of cardiology
n ACS.
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